Lactogens Promote Beta Cell Survival through JAK2/STAT5 Activation and Bcl-XL Upregulation
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
One of the goals in the treatment for diabetes is to enhance pancreatic beta cell function, proliferation, and survival. This study explores the role of lactogenic hormones, prolactin (PRL) and placental lactogen (PL), in beta cell survival. We have previously shown that transgenic mice expressing mouse placental lactogen-1 (mPL1) in beta cells under the rat insulin II promoter (RIP) are resistant to the diabetogenic and cytotoxic effects of streptozotocin (STZ) in vivo. The current study demonstrates that lactogens protect rat insulinoma (INS-1) cells and primary mouse beta cells against two distinct beta cell death inducers, STZ and dexamethasone (DEX), in vitro. Further, we identify the mechanism through which lactogens protect beta cells against DEX-induced death. The signaling pathway mediating this protective effect is the janus-activated-kinase-2/signal transducer and activator of transcription-5 (JAK2/STAT5) pathway. This is demonstrated in INS-1 cells and primary mouse beta cells using three separate approaches, pharmacological inhibitors, JAK2-specific siRNAs and a dominant-negative STAT5 mutant. Furthermore, lactogens specifically and significantly increase the anti-apoptotic protein Bcl-XL in insulinoma cells and mouse islets. Bcl-XL-specific siRNA significantly inhibits lactogen-mediated protection against DEX-induced beta cell death. We believe this is the first direct demonstration of lactogens mediating their protective effect through the JAK2/STAT5 pathway in the beta cell and through Bcl-XL in any cell type.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
From Expansion of β-cell mass in response to pregnancy (2010) · cites this paper as [70]
Citations
Cites
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
Mechanisms involved in the side effects of glucocorticoids
SCHACKE, H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00297-8 · Cited by 1,847
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Sorenson, R., & Brelje, T. (1997) · Hormone and Metabolic Research · doi:10.1055/s-2007-979040 · Cited by 531
Davalli, A. M., Scaglia, L., Zangen, D. H., Hollister, J., Bonner-Weir, S., & Weir, G. C. (1996) · Diabetes · doi:10.2337/diab.45.9.1161 · Cited by 468
Brelje, T. C. (1993) · Endocrinology · doi:10.1210/en.132.2.879 · Cited by 408
Masutani, M., Suzuki, H., Kamada, N., Watanabe, M., Ueda, O., Nozaki, T., Jishage, K.-I., Watanabe, T., Sugimoto, T., Nakagama, H., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2301 · Cited by 286
Freemark, M. (2002) · Endocrinology · doi:10.1210/en.143.4.1378 · Cited by 258
Vasavada, R. C., Garcia-Ocaña, A., Zawalich, W. S., Sorenson, R. L., Dann, P., Syed, M., Ogren, L., Talamantes, F., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.20.15399 · Cited by 212
Self-citation
Research works printed but not linked: 3
- Talamantes, 1990, Prog. Clin. Biol. Res., 342, 81
- Biswas, 1987, Cancer Res., 47, 3509
- Vasavada, R. C., Wang, L., Fujinaka, Y., Takane, K. K., Rosa, T. C., Mellado-Gil, J. M., Friedman, P. A., and Garcia-Ocana, A. (2007) Diabetes, in press
Cited by
Placental hormones and the control of maternal metabolism and fetal growth
Newbern, D., & Freemark, M. (2011) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32834c800d · Cited by 487
Expansion of β-cell mass in response to pregnancy
Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358
“Cish and Socs2 decrease activation of STAT5 [67,68], which has both pro-proliferative (Cyclin D2) [69] and anti-apoptotic (Bcl-xl, Bcl6) targets, as well as targets involved in β-cell function (Figure 3) [56,70].”
BackgroundNatural history of β-cell adaptation and failure in type 2 diabetes
Alejandro, E. U., Gregg, B., Blandino-Rosano, M., Cras-Méneur, C., & Bernal-Mizrachi, E. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.002 · Cited by 232
Peptide Hormone Regulation of Angiogenesis
Clapp, C., Thebault, S., Jeziorski, M. C., & Martínez De La Escalera, G. (2009) · Physiological Reviews · doi:10.1152/physrev.00024.2009 · Cited by 191
“PRL may protect against diabetes, as suggested by the facts that PRL and PL promote the function, proliferation, and survival of -cells (166, 177, 183), and circulating PRL levels are often decreased in poorly controlled diabetic patients (260) and rats (60).”
BackgroundKondegowda, N. G., Fenutria, R., Pollack, I. R., Orthofer, M., Garcia-Ocaña, A., Penninger, J. M., & Vasavada, R. C. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.021 · Cited by 169
“Type 1 (T1D) and Type 2 (T2D) diabetes result from a loss of functional pancreatic b-cell mass caused by b-cell death and dysfunction (Padgett et al., 2013; Weir and Bonner-Weir, 2013).”
InfluentialSelf-citationThe role of oestrogens in the adaptation of islets to insulin resistance
Nadal, A., Alonso‐Magdalena, P., Soriano, S., Ropero, A. B., & Quesada, I. (2009) · The Journal of Physiology · doi:10.1113/jphysiol.2009.177188 · Cited by 149
“The involvement of menin in the β-cell replication (Karnik et al. 2007) and Bcl-XL in the protective effect of PRL has been described (Fujinaka et al. 2007; Hügl & Merger, 2007).”
BackgroundCirculating Prolactin Associates With Diabetes and Impaired Glucose Regulation
Wang, T., Lu, J., Xu, Y., Li, M., Sun, J., Zhang, J., Xu, B., Xu, M., Chen, Y., Bi, Y., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1893 · Cited by 148
Erythropoietin protects against diabetes through direct effects on pancreatic β cells
Choi, D., Schroer, S. A., Lu, S. Y., Wang, L., Wu, X., Liu, Y., Zhang, Y., Gaisano, H. Y., Wagner, K.-U., Wu, H., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100665 · Cited by 128
“JAK2 is described to function downstream of various growth factors, including growth hormone, prolactin, and placental lactogen, which have all been shown to play an essential role in pancreatic -cell homeostasis (Sorenson and Stout, 1995; Cousin et al., 1999; Fujinaka et al., 2007).”
BackgroundDemirci, C., Ernst, S., Alvarez-Perez, J. C., Rosa, T., Valle, S., Shridhar, V., Casinelli, G. P., Alonso, L. C., Vasavada, R. C., & García-Ocana, A. (2012) · Diabetes · doi:10.2337/db11-1154 · Cited by 116
“Steroid hormones have been shown to counteract the mitogenic, prosurvival, and functional effects of PRL/ PL in b cells in vitro (31,32,50), suggesting that upregulation of steroid hormones at the end of pregnancy could be responsible for the increase in b-cell death and normalization of b-cell mass and function.”
BackgroundSelf-citationMechanisms in the adaptation of maternal β-cells during pregnancy
Ernst, S., Demirci, C., Valle, S., Velazquez-Garcia, S., & Garcia-Ocaña, A. (2011) · Diabetes Management · doi:10.2217/dmt.10.24 · Cited by 109
Sibiak, R., Jankowski, M., Gutaj, P., Mozdziak, P. E., Kempisty, B., & Wender-Ożegowska, E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9041142 · Cited by 106
“Furthermore, lactogens participate in the expression of the Bcl-XL antiapoptotic protein, the presence of which is required, independently of the JAK2/STAT5 pathway, to enhance their protective activity in rodent cells [46].”
BackgroundA novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells
Druz, A., Chu, C., Majors, B., Santuary, R., Betenbaugh, M., & Shiloach, J. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23092 · Cited by 92
“Smo and stat5a promote the transcription of bcl2 and bcl-xL genes (Chen et al. 2008; Fujinaka et al. 2007; Xu et al. 2009a; Xu et al. 2009b), which protect the cells from apoptosis resulting from metabolic oxidative stress and reduction of ATP levels due to nutrient deprivation (Lee et al.”
BackgroundPregnancy‐induced changes in β‐cell function: what are the key players?
Salazar‐Petres, E., & Sferruzzi-Perri, A. N. (2021) · The Journal of Physiology · doi:10.1113/jp281082 · Cited by 102
“There may also be protection from apoptosis/enhanced survival (Fujinaka et al. 2007; Karnik et al. 2007) and an increase in the size of β-cells in islets during pregnancy (Parsons et al. 1995; Huang et al. 2009) and thus enhanced viability, hyperplasia and hypertrophy contribute to the expansion of…”
BackgroundAdvancements and challenges in generating accurate animal models of gestational diabetes mellitus
Pasek, R. C., & Gannon, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00425.2013 · Cited by 90
“A key consequence of elevated prolactin is increased -cell proliferation through PrlR signaling mediated by Jak2/Stat5 activation (24, 39).”
BackgroundTerra, L. F., Garay-Malpartida, M., Wailemann, R. A. M., Sogayar, M. C., & Labriola, L. (2011) · Diabetologia · doi:10.1007/s00125-011-2102-z · Cited by 78
“Moreover, using Bclxl-specific small interfering RNA, it was demonstrated that lactogeninduced upregulation of Bclxl is necessary to mediate its protective effect on INS-1 cells against dexamethasoneinduced cell death [18].”
MethodInfluentialRetractedRetnakaran, R., Ye, C., Kramer, C. K., Connelly, P. W., Hanley, A. J., Sermer, M., & Zinman, B. (2016) · Diabetes Care · doi:10.2337/dc16-0043 · Cited by 64
Kaur, T., Singh, H., Mishra, R., Manchanda, S., Gupta, M., Saini, V., Sharma, A., & Kaur, G. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2900-1 · Cited by 67
Yang, Y. H. C., Szabat, M., Bragagnini, C., Kott, K. A., Helgason, C. D., Hoffman, B. G., & Johnson, J. D. (2011) · Diabetologia · doi:10.1007/s00125-010-2012-5 · Cited by 62
“A novel isoform of the anti-apoptotic hormone gastric inhibitory polypeptide is also produced in islets [8, 9]. Growth hormone, prolactin or placental lactogens can promote beta cell survival [ 10 , 11].”
BackgroundArumugam, R., Horowitz, E., Lu, D., Collier, J. J., Ronnebaum, S., Fleenor, D., & Freemark, M. (2008) · Endocrinology · doi:10.1210/en.2008-0051 · Cited by 61
“In addition to up-regulating glucose uptake and use, PRL stimulates -cell proliferation and inhibits -cell apoptosis through induction of cyclin D expression (44) and Bcl-XL (61) and suppression of menin (84).”
BackgroundMelnik, B. C., John, S. M., & Schmitz, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-014-0377-9 · Cited by 65
“It is well known that HPL stimulates the Janus-activatedkinase-2 (JAK2)/STAT5 signaling pathway [108-110].”
BackgroundEmerging diabetes therapies: Bringing back the β-cells
Basile, G., Qadir, M. M. F., Mauvais‐Jarvis, F., Vetere, A., Shoba, V. M., Modell, A. E., Pastori, R. L., Russ, H. A., Wagner, B. K., & Domínguez‐Bendala, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101477 · Cited by 62
Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges
Wang, P., Karaköse, E., Choleva, L., Kumar, K., DeVita, R. J., García-Ocaña, A., & Stewart, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671946 · Cited by 60
Regulation of Pancreatic Islet Beta-Cell Mass by Growth Factor and Hormone Signaling
Huang, Y., & Chang, Y. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00010-7 · Cited by 59
Circulating Prolactin and Risk of Type 2 Diabetes: A Prospective Study
Wang, T., Xu, Y., Xu, M., Ning, G., Lu, J., Dai, M., Xu, B., Sun, J., Sun, W., Lai, S., et al. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv326 · Cited by 58
“During the nonpregnant period, prolactin regulates whole-body insulin sensitivity and glucose metabolism by expanding β-cell mass (12), improving hepatic insulin sensitivity (13), and modulating immune function (5, 7, 14) and has an indirect action by increasing hypothalamic dopamine synthesis to improve energy and gl…”
BackgroundFrench, E. K., Kleinberger, J. W., Salim, F. G., Cox, A. E., Takane, K. K., Scott, D. K., & Stewart, A. F. (2011) · Molecular Endocrinology · doi:10.1210/me.2011-1074 · Cited by 58
Self-citationDefective prolactin signaling impairs pancreatic β-cell development during the perinatal period
Auffret, J., Freemark, M., Carré, N., Mathieu, Y., Tourrel-Cuzin, C., Lombès, M., Movassat, J., & Binart, N. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00636.2012 · Cited by 46
Prolactin Supplementation to Culture Medium Improves β-Cell Survival
Yamamoto, T., Mita, A., Ricordi, C., Messinger, S., Miki, A., Sakuma, Y., Timoneri, F., Barker, S., Fornoni, A., Molano, R. D., et al. (2010) · Transplantation · doi:10.1097/tp.0b013e3181d98af1 · Cited by 41
“(16) reported that lactogens, including PRL, directly protect rodent pancreatic cells against the cytotoxic effects of STZ and dexamethasone.”
BackgroundLombardo, M. F., De Angelis, F., Bova, L., Bartolini, B., Bertuzzi, F., Nano, R., Capuani, B., Lauro, R., Federici, M., Lauro, D., et al. (2011) · Islets · doi:10.4161/isl.3.5.16900 · Cited by 37
Kondegowda, N. G., Mozar, A., Chin, C., Otero, P. A., García-Ocaña, A., & Vasavada, R. C. (2012) · Diabetologia · doi:10.1007/s00125-012-2501-9 · Cited by 37
“The 200 ng/ml dose of lactogens was chosen based on our previous research [26] and a current dose response study (Fig.”
BackgroundMethodInfluentialSelf-citationArumugam, R., Horowitz, E., Noland, R. C., Lu, D., Fleenor, D. E., & Freemark, M. (2010) · Endocrinology · doi:10.1210/en.2010-0049 · Cited by 32
Nair, S., Ormazábal, V., Lappas, M., McIntyre, D. H., & Salomón, C. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13361 · Cited by 31
Hypothalamic Control of Prolactin Secretion, and the Multiple Reproductive Functions of Prolactin
Grattan, D. R., & Tissier, P. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00012-0 · Cited by 39
Metabolic evolution suggests an explanation for the weakness of antioxidant defences in beta-cells
Rashidi, A., Kirkwood, T. B. L., & Shanley, D. P. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.12.007 · Cited by 34
Research Progress on the Experimental Animal Model of Gestational Diabetes Mellitus
He, Y., Wu, N., Yu, W., Li, L., Ouyang, H., Liu, X., Qian, M., & Al-Mureish, A. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s270935 · Cited by 34
Arumugam, R., Fleenor, D. E., Lu, D., & Freemark, M. (2011) · Endocrinology · doi:10.1210/en.2010-1258 · Cited by 29
“The surge in lactogen levels and induction of PRLR expression in the perinatal period and pregnancy likely promote -cell expansion and insulin production, because lactogen treatment of human or rodent islets (7–11, 50) or overexpression of PL in pancreatic -cells (12, 13) stimulates -cell replication and GSIS and prol…”
Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders
Walz, C., Cross, N. C. P., Etten, R. A. V., & Reiter, A. (2008) · Leukemia · doi:10.1038/leu.2008.133 · Cited by 32
Redox regulation of Janus kinase: The elephant in the room
Duhé, R. J. (2013) · JAK-STAT · doi:10.4161/jkst.26141 · Cited by 31
Vasoinhibins: novel inhibitors of ocular angiogenesis
Clapp, C., Thébault, S. C., Arnold, E., García, C., Rivera, J. C., & de la Escalera, G. M. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90358.2008 · Cited by 27
“proliferation, and survival of beta cells in normal physiology and in pregnancy (32, 34-36, 77).”
BackgroundA Century of Prolactin: Emerging Perspectives as a Metabolic Regulator
Wu, T., Duan, Y., Jiang, J., Gu, T., Zhang, P., & Bi, Y. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3836 · Cited by 29
Arumugam, R., Fleenor, D., & Freemark, M. (2013) · Endocrine · doi:10.1007/s12020-013-0073-1 · Cited by 27
Relationship Between Human Periodontitis and Type 2 Diabetes at a Genomic Level: A Data‐Mining Study
Covani, U., Marconcini, S., Derchi, G., Barone, A. A., & Giacomelli, L. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080671 · Cited by 28
O-GlcNAc transferase contributes to sex-specific placental deregulation in gestational diabetes
Cui, Y., Cruz, M., Palatnik, A., & Stichelen, S. O.-V. (2022) · Placenta · doi:10.1016/j.placenta.2022.11.006 · Cited by 26
An investigation of the association between the level of prolactin in serum and type II diabetes
Manshaei, N., Shakibaei, F., Fazilati, M., Salavati, H., Negahdary, M., & Palizban, A. (2018) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2018.07.007 · Cited by 26
Mortlock, R. D., Georgia, S. K., & Finley, S. D. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00647-8 · Cited by 28
Jiao, Y., Rieck, S., Lay, J. E. L., & Kaestner, K. H. (2013) · Diabetologia · doi:10.1007/s00125-013-3014-x · Cited by 20
Placental Endocrine Function and Hormone Action
Albrecht, E. D., & Pepe, G. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00040-5 · Cited by 20
Global Deletion of the Prolactin Receptor Aggravates Streptozotocin-Induced Diabetes in Mice
Ramírez‐Hernández, G., Adán‐Castro, E., Díaz‐Lezama, N., Ruíz‐Herrera, X., de la Escalera, G. M., Macotela, Y., & Clapp, C. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.619696 · Cited by 19
Association of Serum Prolactin Level with Impaired Glucose Regulation and Diabetes.
Chahar, C., Chahar, K., Ankit, B. S., Gadhwal, A., & Agrawal, R. P. (2017) · PubMed · Cited by 17
Admin, A., Li, R., Kondegowda, N. G., Filipowska, J., Hampton, R. F., Leblanc, S., García-Ocaña, A., & Vasavada, R. C. (2020) · Diabetes · doi:10.2337/db19-0909 · Cited by 17
“b-cell death was quantified as the percentage of insulin and TUNEL-positive over total insulin–positive cells (24,36).”
BackgroundMethodSelf-citationModelling gestational diabetes mellitus: large animals hold great promise
Gao, X., He, J., Zhu, A., Xie, K., Yan, K., Jiang, X. X., Xu, Y., Li, Q., Xu, A., Ye, D., et al. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09617-x · Cited by 20
NRF2 deficiency leads to inadequate beta cell adaptation during pregnancy and gestational diabetes
Haidery, F., Lambertini, L., Tse, I., Dodda, S., García-Ocaña, A., Scott, D. K., & Baumel-Alterzon, S. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103566 · Cited by 16
“…DMEM supplemented with 5.5 mM glucose and 1 % P/S for 16 h. Media was then replaced to a similar media supplemented with 1 % Bovine serum albumin (BSA) and Mouse prolactin (Sigma-Aldrich SRP4688, diluted in serum-free DMEM media containing 0.1 % BSA) for 6 h, as previously described [50,99,100].”
InfluentialXiao, Z., Liang, J. Y., Deng, Q., Song, C., Yang, X., Liu, Z., Shao, Z., Zhang, K., Wang, X., & Li, Z. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4784 · Cited by 16
Role of Prolactin in the Metabolic Adaptations to Pregnancy and Lactation
Woodside, B. C., Augustine, R. A., Ladyman, S. R., Naef, L., & Grattan, D. R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374285-8.00016-0 · Cited by 16
Chen, G., Liu, C., Xue, Y., Mao, X., Xu, K., & Liu, C. (2010) · Endocrine · doi:10.1007/s12020-010-9421-6 · Cited by 15
“Previous literature reported that the effect of PRL on INS-1 b-cells proliferation and function may be mediated by activation of the JAK‐STAT pathway [29, 30 ].”
BackgroundHuber, H. A., Georgia, S. K., & Finley, S. D. (2022) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2022.111341 · Cited by 13
“…anti-apoptotic protein B-cell lymphoma-extra large (BCL-xL), influence cell phenotype, while others, such as inhibitor protein Suppressor of Cytokine Signaling (SOCS), form feedback loops with proteins upstream in the pathway to control cell signaling (Fujinaka et al., 2007; Rieck et al., 2009)..”
BackgroundMethodInfluentialSuppression of FAT/CD36 mRNA by human growth hormone in pancreatic β-cells
Dalgaard, L. T., Thams, P., Gaarn, L. W., Jensen, J., Lee, Y. C., & Nielsen, J. H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.010 · Cited by 12
Prolactin effect on blood glucose and insülin in breastfeeding women
Özışık, H., Süner, A., & Çetinkalp, Ş. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.03.045 · Cited by 11
Exogenous Lactogenic Signaling Stimulates Beta Cell Replication In Vivo and In Vitro
Millette, K., Rodriguez, K., Sheng, X., Finley, S. D., & Georgia, S. K. (2022) · Biomolecules · doi:10.3390/biom12020215 · Cited by 10
“This is mediated through STAT5A activation and translocation into the nucleus [9,20].”
BackgroundResultAlkharusi, A., de Mirecki-Garrido, M., Ma, Z., Zadjali, F., Flores‐Morales, A., Nyström, T., Castrillo, A., Björklund, A., Norstedt, G., & Fernández‐Pérez, L. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0036 · Cited by 10
“Speculatively, deletion of SOCS2 in beta cells creates a situation similar to pregnancy, characterized by increased PRL/GH stimulation of beta cells that in turn can stimulate STAT5 activity leading to cell proliferation and survival [25, 24].”
BackgroundDrug-induced regeneration of pancreatic beta cells: An approach to cellular therapeutic targets
Parsi, P., Saharkhiz, S., Farani, M. R., Bakhtiyari, S., & Alipourfard, I. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00255-9 · Cited by 9
“This can occur through an autocrine mechanism, where the cells release these molecules and then respond to them themselves, or through a paracrine mechanism, where neighboring cells respond to the released molecules (Fujinaka et al. 2007; Butler et al. 2010).”
Prolactin levels and cardiovascular disease: a complicate relationship or a confounding association?
Papazoglou, Α. S., & Leite, A. R. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad176 · Cited by 9
STAT5 activity in pancreatic β-cells
Dalgaard, L. T., Billestrup, N., & Nielsen, J. H. (2008) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.3.4.423 · Cited by 9
Magnetogenetic cell activation using endogenous ferritinPreprint
Pomeranz, L. E., Li, R., Yu, X., Kelly, L., Hassanzadeh, G., Molina, H., Gross, D., Brier, M. I., Vaisey, G., Wang, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.06.20.545120 · Cited by 7
“Islet Isolation and Ex Vivo Studies: Islets from Ins1-cre mice injected with AAV8-JeT-DIO-Nb-FT-2TRPV1 or AAV8-JeT-DIO-mCherry were isolated by collagenase digestion at 37oC and histopaque gradient separation as previously described(50-52).”
MethodLGR4 is essential for maintaining β-cell homeostasis through suppression of RANK
Filipowska, J., Cisneros, Z., Varghese, S. S., Leon-Rivera, N., Wang, P., Kang, R. B., Lu, G., Yuan, Y., Shih, H.-P., Bhattacharya, S., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102097 · Cited by 7
Self-citationEl-Eshmawy, M. M., Elkhamisy, E. M., Elsayed, E., & Kamal, S. (2017) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2017.41.3.195 · Cited by 8
“From a mechanistic perspective, prolactin takes a crucial part in regulating whole-body insulin sensitivity and glucose metabolism by increasing β-cell proliferation, promoting cumulative insulin secretion, and inhibiting key caspases of the extrinsic and intrinsic pathways leading to islets apoptosis, and modulating…”
BackgroundPhosphatases are predicted to govern prolactin-mediated JAK–STAT signaling in pancreatic beta cells
Simoni, A. D., Huber, H. A., Georgia, S. K., & Finley, S. D. (2022) · Integrative Biology · doi:10.1093/intbio/zyac004 · Cited by 6
Urreta, I., Oyanguren, I., & Castañón, S. (2010) · Transgenic Research · doi:10.1007/s11248-010-9452-z · Cited by 6
“Therefore PL, together with Hepatocyte Growth Factor (Lopez-Talavera et al. 2004) and Parathyroid Hormone-related Protein (Cebrian et al. 2002), belongs to the short list of growth factors capable of improving all three critical beta cell parameters, namely function, proliferation and survival; the latter are ideal ch…”
BackgroundPossible mechanisms involved in improved beta cell function in pregnant women with type 1 diabetes
Nalla, A., Ringholm, L., Sørensen, S. N., Damm, P., Mathiesen, E. R., & Nielsen, J. H. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e04569 · Cited by 6
“This may also be due to an increase in circulating levels of lactogenic hormones during pregnancy as they have anti-apoptotic effects in beta cells [25, 26, 27].”
Backgroundc-Jun regulates postpartum β-cell apoptosis and survival downstream of prolactin signaling
Chung, J., Ruiz-Otero, N., & Banerjee, R. R. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112570 · Cited by 5
The redundant role of JAK2 in regulating pancreatic β-cell mass
Choi, D., Cai, E. P., & Woo, M. (2011) · Islets · doi:10.4161/isl.3.6.18158 · Cited by 5
On the Surprising Weakness of Pancreatic Beta-Cell Antioxidant Defences: An Evolutionary Perspective
Rashidi, A., Kirkwood, T. B. L., & Shanley, D. P. (2009) · Springer eBooks · doi:10.1007/978-3-642-00952-5_6 · Cited by 5
“‐Arumugam et al. 2008; Fujinaka et al. 2007 ‐Sorenson and Brelje 1997”
Growth Factor Mediated Regulation of Beta Cell Survival
Vasavada, R. C. (2010) · The Open Endocrinology Journal · doi:10.2174/1874216501004010078 · Cited by 6
Self-citationIwasaki, K., Carapeto, P., Abarca, C., Hela, F., Sanjines, S., Pena, S., Le, S., Pan, H., Jackson, M., Cahill, C., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.197310 · Cited by 4
“Prolactin-induced JAK2/STAT5 activation promotes β cell survival by increasing the expression of antiapoptotic protein BCL-XL and protects against glucolipotoxicity-induced cell death in rodent and human β cells (22, 23).”
Urreta, I., & Casta, S. (2012) · InTech eBooks · doi:10.5772/31515 · Cited by 3
“Therefore, hPL together with other peptidic growth factors (HGF and PTHrP) belongs to the short list of proteins capable of improving the critical beta cell parameters, namely function, proliferation and survival, to improve tissue availability for islet transplantation (Fujinaka et al. 2007).”
BackgroundDimić, N., Maric, G. D., Oreščanin-Dušić, Z., Grahovac, T. M., Uzelac, T. V., Djuric, M. D., Nenadic, I. B., Bobos, M. M., Stevanovic, P. D., Mihajlovic, S., et al. (2025) · Life · doi:10.3390/life15081158 · Cited by 2
“Prolactin affects insulin sensitivity and glucose metabolism, enhances hepatic insulin sensitivity, and disrupts immune function [24,25].”
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
Barcelos, M. M., & Santos‐Silva, M. C. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110079 · Cited by 2
“Among the proteins involved in signaling pathways are the transcription activating proteins and signal transducers (STATs), especially STAT5, which, among other functions, positively regulate the production of the anti-apoptotic protein Bcl-xL.(31) Dimerization of this protein and translocation to the cell nucleus occ…”
BackgroundThe Potential Impact of Maternal Milk Consumption During Pregnancy on mTORC1-Driven Fetal Growth
Melnik, B. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-14874-8_18 · Cited by 2
Some Aspects of Endocrinology of the Placenta
Longo, L. D. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7483-2_9 · Cited by 2
Joseph, A., Nair, L. C. R., Johnson, B. S., Thomas, P. L., Padmanabhan, R. A., Puthumadathil, N., & Laloraya, M. (2019) · Cellular Physiology and Biochemistry · doi:10.33594/000000010 · Cited by 1
Mansano, R. A. W. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2013.tde-22102013-112950 · Cited by 5
Terra, L. F. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2013.tde-06082013-113611 · Cited by 1
Role of Reproductive Hormones in Islet Adaptation to Metabolic Stress
Álvarez‐Mercado, A. I., Navarro, G., & Mauvais‐Jarvis, F. (2014) · Springer eBooks · doi:10.1007/978-94-007-6884-0_44-3
“PRL-induced increases in insulin secretion and b-cell proliferation are also mediated by the JAK2/STAT5 pathway (Brelje et al. 2002; Fujinaka et al. 2007).”
BackgroundInfluentialGómez, I. U. (2012) · Communities in ADDI (Universidad del Pais Vasco)
Wojciechowski, I. T. (2011) · Otago University Research Archive (University of Otago)
Avaliação do papel de HSPB1 na modulação da autofagia induzida por PRL em células-beta
da Silva, F. F. A. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2018.tde-24082018-092045
Mansano, R. A. W. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2019.tde-07052019-111824 · Cited by 1
Leslie, K. A. (2019) · Figshare
Penno, J. R. C. Z. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2021.tde-11012022-095518 · Cited by 1
Role of Reproductive Hormones in Islet Adaptation to Metabolic Stress
Álvarez‐Mercado, A. I., Navarro, G., & Mauvais‐Jarvis, F. (2014) · Springer eBooks · doi:10.1007/978-94-007-6686-0_44
Transcriptomic modifications in maternal pancreatic islets during the period around weaning in mice
Burgos-Gamez, X., Morales-Castillo, P., Hernández-Vázquez, A. D. J., Pastén-Hidalgo, K., García-Vázquez, F., & Fernández‐Mejía, C. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112642
Cherchia, L., Fraser, S. E., Finley, S. D., & Schneider, F. (2025) · bioRxiv · doi:10.1101/2025.10.14.682359
“Further, many studies of PRLR signaling em-75 ploy immunoblotting to detect levels of downstream signaling proteins in fixed tissues (Brelje et al., 2002, 2004; Fujinaka et al., 2007).”
InfluentialImpact des hormones lactogènes sur la cellule β pancréatique et l’adipocyte
Auffret, J. (2012) · theses.fr (ABES) · doi:10.70675/cb20892aza73cz47bfz9fa6zec0fb7d1634e · Cited by 1
Chen, W., Li, M., Feng, J., Qu, W., Zhang, X., Li, S., Sha, S., Xue, X., Jiang, K., & Wan, H. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s625196
A systems-level approach to the evolution of ageing
Rashidi, A. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Metadata
- Authors
- Fujinaka, Y., Takane, K., Yamashita, H., & Vasavada, R. C.
- Affiliations
- University of Pittsburgh (US)
- Nagoya City University (JP)
- Corresponding author
- Vasavada, Rupangi C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-10
- Volume
- 282
- Issue
- 42
- Pages
- 30707-30717
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2034353384
- Cited by
- 92
- References
- 44
- Citations by year
- 2025: 7 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 3 · 2017: 2 · 2016: 4 · 2015: 3 · 2014: 6 · 2013: 9 · 2012: 4
- FWCI
- 5.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4739 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-072264, R01DK072264)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- lactogen, prolactin, placental lactogen, beta-cell survival, JAK2/STAT5 signaling, Bcl-xL, beta-cell death, dexamethasone, streptozotocin, insulinoma cells, islets, diabetes mellitus
- MeSH terms
- Animals, Anti-Inflammatory Agents, Cell Survival, Dexamethasone, Diabetes Mellitus, Experimental, Genes, Dominant, Insulin, Mice, Transgenic, Mutation, Placental Lactogen, Prolactin, Promoter Regions, Genetic, Signal Transduction, Up-Regulation, Cell Death, Cytoprotection, RNA, Small Interfering, Cell Line, Tumor, Insulin-Secreting Cells, STAT5 Transcription Factor, bcl-X Protein, Mice, Rats, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.